$ACCD
Accolade, Inc. Stock $accd

$accd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000155837023007137 Filed on April 28, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$93.23M	$99.03M	$363.1M
YoY Change	9.0%	5.62%	17.13%
Cost Of Revenue	$54.20M	$51.05M	$198.9M
YoY Change	13.84%	17.1%	17.68%
Gross Profit	$39.02M	$47.98M	$164.2M
YoY Change	2.93%	-4.36%	16.48%
Gross Profit Margin	41.86%	48.45%	45.23%
Selling, General & Admin	$67.01M	$67.54M	$180.3M
YoY Change	46.15%	-10.5%	-2.99%
% of Gross Profit	171.72%	140.77%	109.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.64M	$11.63M	$46.38M
YoY Change	0.55%	-0.11%	8.85%
% of Gross Profit	29.83%	24.24%	28.24%
Operating Expenses	$78.65M	$79.16M	$627.8M
YoY Change	-79.52%	-1.0%	135.35%
Operating Profit	-$39.63M	-$31.19M	-$463.5M
YoY Change	-88.55%	4.65%	268.67%
Interest Expense	$921.0K	$739.0K	$255.0K
YoY Change	-245.27%	-196.22%	-108.78%
% of Operating Profit
Other Income/Expense, Net	$390.0K	-$36.00K	-$15.00K
YoY Change	-880.0%	-68.42%	-88.72%
Pretax Income	-$38.32M	-$30.48M	-$463.3M
YoY Change	-88.95%	-0.68%	259.79%
Income Tax	$91.00K	-$51.00K	-$3.624M
% Of Pretax Income
Net Earnings	-$38.41M	-$30.43M	-$459.7M
YoY Change	-88.8%	-11.93%	273.32%
Net Earnings / Revenue	-41.2%	-30.73%	-126.58%
Basic Earnings Per Share	-$0.52		-$6.45
Diluted Earnings Per Share	-$0.52	-$0.42	-$6.45
COMMON SHARES
Basic Shares Outstanding	73.63M		71.28M
Diluted Shares Outstanding	73.18M		71.28M

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$302.9M	$321.1M	$321.1M
YoY Change	-9.76%	-12.24%	-12.24%
Cash & Equivalents	$302.9M	$321.1M	$321.1M
Short-Term Investments
Other Short-Term Assets	$19.31M	$18.17M	$18.17M
YoY Change	43.41%	45.57%	45.57%
Inventory
Prepaid Expenses
Receivables	$26.30M	$23.44M	$26.70M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$348.5M	$365.9M	$365.9M
YoY Change	-7.71%	-10.56%	-10.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$44.69M	$14.76M	$44.29M
YoY Change	276.64%	25.14%	-1.41%
Goodwill	$278.2M	$278.2M
YoY Change	0.0%	-51.86%
Intangibles	$192.8M	$203.2M
YoY Change	-17.71%	-16.96%
Long-Term Investments
YoY Change
Other Assets	$11.53M	$1.624M	$11.44M
YoY Change	631.75%	-3.22%	28.77%
Total Long-Term Assets	$527.2M	$537.1M	$537.1M
YoY Change	-7.0%	-38.71%	-38.71%
TOTAL ASSETS
Total Short-Term Assets	$348.5M	$365.9M	$365.9M
Total Long-Term Assets	$527.2M	$537.1M	$537.1M
Total Assets	$875.7M	$903.1M	$903.1M
YoY Change	-7.28%	-29.75%	-29.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.461M	$10.16M	$10.16M
YoY Change	-29.78%	29.58%	29.58%
Accrued Expenses	$48.33M	$11.74M	$58.37M
YoY Change	21.68%	6.76%	23.06%
Deferred Revenue	$44.19M	$35.19M
YoY Change	19.81%	13.98%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$600.0K
YoY Change			0.67%
Total Short-Term Liabilities	$112.7M	$119.4M	$119.4M
YoY Change	18.07%	6.86%	6.86%
LONG-TERM LIABILITIES
Long-Term Debt	$282.7M	$282.3M	$282.3M
YoY Change	0.59%	0.59%	0.59%
Other Long-Term Liabilities	$26.05M	$203.0K	$27.55M
YoY Change	4527.18%	-95.55%	-26.18%
Total Long-Term Liabilities	$308.8M	$203.0K	$309.9M
YoY Change	54747.78%	-95.55%	-2.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$112.7M	$119.4M	$119.4M
Total Long-Term Liabilities	$308.8M	$203.0K	$309.9M
Total Liabilities	$421.5M	$429.3M	$429.3M
YoY Change	2.83%	-0.11%	-0.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$992.7M	-$954.3M
YoY Change	18.54%	92.93%
Common Stock	$8.000K	$7.000K
YoY Change	14.29%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$454.2M	$473.8M	$473.8M
YoY Change
Total Liabilities & Shareholders Equity	$875.7M	$903.1M	$903.1M
YoY Change	-7.28%	-29.75%	-29.75%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$38.41M	-$30.43M	-$459.7M
YoY Change	-88.8%	-11.93%	273.32%
Depreciation, Depletion And Amortization	$11.64M	$11.63M	$46.38M
YoY Change	0.55%	-0.11%	8.85%
Cash From Operating Activities	-$19.29M	-$2.559M	-$40.71M
YoY Change	-36.68%	12.04%	-34.72%
INVESTING ACTIVITIES
Capital Expenditures	$3.377M	$2.413M	$2.105M
YoY Change	567.39%	-444.22%	-16.5%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$3.377M	-$2.413M	-$7.228M
YoY Change	165.49%	353.57%	-97.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.451M	418.0K	3.163M
YoY Change	195.16%	-84.44%	-98.77%
NET CHANGE
Cash From Operating Activities	-19.29M	-2.559M	-40.71M
Cash From Investing Activities	-3.377M	-2.413M	-7.228M
Cash From Financing Activities	4.451M	418.0K	3.163M
Net Change In Cash	-18.21M	-4.554M	-44.77M
YoY Change	-39.74%	3430.23%	-34.19%
FREE CASH FLOW
Cash From Operating Activities	-$19.29M	-$2.559M	-$40.71M
Capital Expenditures	$3.377M	$2.413M	$2.105M
Free Cash Flow	-$22.66M	-$4.972M	-$42.81M
YoY Change	-26.81%	214.09%	-34.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001481646
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67098477
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73089075
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023	accd	Goodwill Impairment Adjustment Per Shares Diluted GoodwillImpairmentAdjustmentPerSharesDiluted	4.20
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y0M29D
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39348
CY2023	dei	Entity Registrant Name EntityRegistrantName	ACCOLADE, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	01-0969591
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1201 Third Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1700
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
CY2023	dei	City Area Code CityAreaCode	206
CY2023	dei	Local Phone Number LocalPhoneNumber	926-8100
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	ACCD
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	658500000000
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73634043
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Philadelphia, PA
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	321083000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	365853000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23435000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21116000
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	3260000
CY2022Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9685000
CY2023Q1	accd	Deferred Acquisition Costs Current DeferredAcquisitionCostsCurrent	4022000
CY2022Q1	accd	Deferred Acquisition Costs Current DeferredAcquisitionCostsCurrent	3015000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14149000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9468000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	365949000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	409137000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14763000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11797000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29525000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33126000
CY2023Q1	us-gaap	Goodwill Goodwill	278191000
CY2022Q1	us-gaap	Goodwill Goodwill	577896000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	203202000
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244690000
CY2023Q1	accd	Deferred Acquisition Costs Non Current DeferredAcquisitionCostsNonCurrent	9815000
CY2022Q1	accd	Deferred Acquisition Costs Non Current DeferredAcquisitionCostsNonCurrent	7205000
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1624000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1678000
CY2023Q1	us-gaap	Assets Assets	903069000
CY2022Q1	us-gaap	Assets Assets	1285529000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10155000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7837000
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11744000
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11000000
CY2023Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	39346000
CY2022Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	39189000
CY2023Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	15694000
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	16263000
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35191000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30875000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7284000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6589000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	119414000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	111753000
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	282323000
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	280666000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27189000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32486000
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	203000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4562000
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	154000
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	268000
CY2023Q1	us-gaap	Liabilities Liabilities	429283000
CY2022Q1	us-gaap	Liabilities Liabilities	429735000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73089075
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67098477
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7000
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	7000
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1428073000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1350431000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-954294000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-494644000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	473786000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	855794000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	903069000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1285529000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	363142000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	310021000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170358000
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	198905000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	169019000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	93673000
CY2023	accd	Product And Technology Expense ProductAndTechnologyExpense	101347000
CY2022	accd	Product And Technology Expense ProductAndTechnologyExpense	83664000
CY2021	accd	Product And Technology Expense ProductAndTechnologyExpense	49955000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	99113000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	86765000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	33711000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81209000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	99106000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31584000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46377000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42608000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8212000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-45416000
CY2023	us-gaap	Operating Expenses OperatingExpenses	627751000
CY2022	us-gaap	Operating Expenses OperatingExpenses	266727000
CY2021	us-gaap	Operating Expenses OperatingExpenses	123462000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-463514000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-125725000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-46777000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	255000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2905000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3724000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-133000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-147000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-463274000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128763000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-50648000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3624000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5639000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-50652000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.93
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.93
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71279831
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71279831
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63823270
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63823270
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29370594
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29370594
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-256795000
CY2021	accd	Stock Issued During Period Value Stock Options And Common Stock Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndCommonStockWarrantsExercised	9272000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	233022000
CY2021	accd	Adjustments To Additional Paid In Capital Stock Options For Bonus Satisfaction AdjustmentsToAdditionalPaidInCapitalStockOptionsForBonusSatisfaction	5735000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	156000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1259000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9576000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-50652000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	390848000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	456593000
CY2022	accd	Issuance Of Replacement Awards In Connection With Acquisition IssuanceOfReplacementAwardsInConnectionWithAcquisition	6729000
CY2022	accd	Contingent Share Earnout In Connection With Acquisitions ContingentShareEarnoutInConnectionWithAcquisitions	73481000
CY2022	accd	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits	8522000
CY2022	accd	Adjustments To Additional Paid In Capital Capped Calls Purchased AdjustmentsToAdditionalPaidInCapitalCappedCallsPurchased	34503000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4309000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72939000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	855794000
CY2023	accd	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits	2071000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2927000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72644000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	473786000
CY2023	us-gaap	Profit Loss ProfitLoss	-459650000
CY2022	us-gaap	Profit Loss ProfitLoss	-123124000
CY2021	us-gaap	Profit Loss ProfitLoss	-50652000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46377000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42608000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8212000
CY2023	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	3698000
CY2022	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	2945000
CY2021	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	1657000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-45416000
CY2023	accd	Deferred Income Tax Expense Benefit Related To Acquisition DeferredIncomeTaxExpenseBenefitRelatedToAcquisition	3997000
CY2022	accd	Deferred Income Tax Expense Benefit Related To Acquisition DeferredIncomeTaxExpenseBenefitRelatedToAcquisition	6132000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1660000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	1673000
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	2252000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	72644000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	72939000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9576000
CY2023	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	-4106000
CY2022	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	11829000
CY2021	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	10648000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1131000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1899000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2991000
CY2023	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	7314000
CY2022	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	4148000
CY2021	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	4690000
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3634000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13986000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2700000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	157000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2519000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16356000
CY2023	accd	Increase Decrease In Deferred Rent And Other Liabilities IncreaseDecreaseInDeferredRentAndOtherLiabilities	1627000
CY2022	accd	Increase Decrease In Deferred Rent And Other Liabilities IncreaseDecreaseInDeferredRentAndOtherLiabilities	-106000
CY2021	accd	Increase Decrease In Deferred Rent And Other Liabilities IncreaseDecreaseInDeferredRentAndOtherLiabilities	-505000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4483000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1328000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2919000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40705000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62350000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25232000
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5123000
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1096000
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	374000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2105000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2521000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1991000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	99998000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	99998000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	259996000
CY2021	accd	Earnout Payments In Acquisition EarnoutPaymentsInAcquisition	58000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7228000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-263613000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2423000
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	2927000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4703000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	2379000
CY2023	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	2064000
CY2022	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	8600000
CY2021	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	9348000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1828000
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	60000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8368000
CY2022	accd	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	34443000
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	287500000
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	51166000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	439410000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	73166000
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	753000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3163000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	257932000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	428384000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-44770000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-68031000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	400729000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	365853000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	433884000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33155000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321083000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	365853000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	433884000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1640000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	930000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2296000
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5735000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	771000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	161000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	232000
CY2023	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	13000
CY2022	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	4000
CY2021	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	97000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	157000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	122000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	149000
CY2022	us-gaap	Stock Issued1 StockIssued1	455586000
CY2023Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	3700000
CY2021	us-gaap	Stock Issued1 StockIssued1	156000
CY2022	accd	Replacement Awards Issued In Connection With Acquisition ReplacementAwardsIssuedInConnectionWithAcquisition	6729000
CY2020Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29479521
CY2020Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1401836
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including the fair value of assets acquired and liabilities assumed for business combinations, unbilled revenues and deferred revenues, certain accrued expenses, stock-based compensation, assessment of the useful life and recoverability of long-lived assets, income taxes, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, assessment of the recoverability of goodwill, and the reported amounts of revenues and expenses during the reporting period. To the extent there are material differences between these estimates, judgments, or assumptions and actual results, the Company’s financial statements will be affected.</p>
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. The Company maintains its cash primarily with domestic financial institutions of high credit quality, which may exceed federal deposit insurance corporation limits. The Company invests its cash equivalents in highly rated money market funds and U.S. treasury bills with original maturities of three months or less. Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Significant customers are those which represent 10% or more of the Company’s revenue during the period. For each significant customer, revenue as a percentage of total revenue was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.89%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended February 28,</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:9pt;margin:0pt 0pt 12pt 36pt;">*For the fiscal years ended February 28, 2023 and 2022, no customer represented 10% or more of the Company’s revenue.</p>
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	363142000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	310021000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	152976000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	56778000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	14888000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	372000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	34000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	225048000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	30567000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25817000
CY2023	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	3768000
CY2022	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	4673000
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	484000
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2022	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	324367000
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	249028000
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-137644000
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-142392000
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1218000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	13219000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2050000
CY2021Q1	us-gaap	Goodwill Goodwill	4013000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	573883000
CY2022Q1	us-gaap	Goodwill Goodwill	577896000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000
CY2023Q1	us-gaap	Goodwill Goodwill	278191000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000
CY2023	accd	Goodwill Impairment Adjustment Per Shares Basic GoodwillImpairmentAdjustmentPerSharesBasic	4.20
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023Q1	accd	Goodwill Impairment Test Discount Rate GoodwillImpairmentTestDiscountRate	0.11
CY2023Q1	accd	Goodwill Impairment Test For Current Revenue GoodwillImpairmentTestForCurrentRevenue	1.1
CY2023Q1	accd	Goodwill Impairment Test For Forward Revenue GoodwillImpairmentTestForForwardRevenue	1.8
CY2023	accd	Excess Of Fair Value Over Carrying Value ExcessOfFairValueOverCarryingValue	0
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	283576000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	80374000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	203202000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	283576000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38886000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	244690000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	41488000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36590000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1450000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	37795000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	34143000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	32125000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9403000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7370000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	82366000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	203202000
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69606000
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61767000
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54843000
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49970000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14763000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11797000
CY2023	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	4889000
CY2022	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	6018000
CY2021	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	6762000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7575000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	7169000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2042000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1691000
CY2023	us-gaap	Lease Cost LeaseCost	9617000
CY2022	us-gaap	Lease Cost LeaseCost	8860000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	8569000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	8310000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2170000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3564000
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8849000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7270000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7303000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6420000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3665000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5732000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39239000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4766000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	34473000
CY2023Q1	accd	Lessee Operating Lease Lease Not Yet Commenced Minimum Lease Payment LesseeOperatingLeaseLeaseNotYetCommencedMinimumLeasePayment	5700000
CY2023Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P8Y
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	596000
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	596000
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1992000
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2661000
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	528000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	769000
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	347000
CY2022Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1492000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	202000
CY2022Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	888000
CY2023Q1	accd	Accrued Software Hardware And Communication Costs AccruedSoftwareHardwareAndCommunicationCosts	464000
CY2022Q1	accd	Accrued Software Hardware And Communication Costs AccruedSoftwareHardwareAndCommunicationCosts	600000
CY2022Q1	accd	Accrued Payable Related To Acquisition Earnout Current AccruedPayableRelatedToAcquisitionEarnoutCurrent	1969000
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4117000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2025000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11744000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11000000
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	120866000
CY2023	accd	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Fair Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue	-45416000
CY2023	accd	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transition To Equity Classification FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransitionToEquityClassification	-75450000
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0
CY2023Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	221346000
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	1208000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72644000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	141000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72939000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9576000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7996056
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2167775
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.47
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1182099
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.98
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	257963
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8723769
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	528038
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	47.74
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	901064
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.37
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	304951
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.87
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8045792
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	915081
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.06
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	346518
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	563836
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.05
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8050519
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	30430000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7893273
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.43
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	30106000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6581769
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.11
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M18D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	27765000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	76000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	37000
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.035
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	100000
CY2023	accd	Defined Contribution Plan Employers Matching Contribution Vesting Number Of Years Of Service DefinedContributionPlanEmployersMatchingContributionVestingNumberOfYearsOfService	P4Y
CY2023	accd	Defined Contribution Plan Employer Discretionary Profit Sharing Contribution Vesting Number Of Years Of Service DefinedContributionPlanEmployerDiscretionaryProfitSharingContributionVestingNumberOfYearsOfService	P4Y
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3231000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2278000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1599000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-463848000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-129569000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-50934000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	574000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	806000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	286000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-463274000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128763000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-50648000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	156000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	124000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	90000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	127000
CY2023Q1	accd	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	113740000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	373000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	402000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	178000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1638000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7935000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2359000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1941000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-47000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-174000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3997000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6041000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-174000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3624000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5639000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.028
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.045
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.046
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.021
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.002
CY2022	accd	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCosts	-0.011
CY2021	accd	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCosts	0.000
CY2022	accd	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0.011
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.086
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.119
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.219
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.254
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.044
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2023	accd	Reversal Of Deferred Tax Liability ReversalOfDeferredTaxLiability	3899000
CY2022Q1	accd	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	114272000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5599000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5210000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	32741000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	16353000
CY2023Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3092000
CY2022Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3082000
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	6248000
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	869000
CY2022Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	578000
CY2023Q1	accd	Deferred Tax Asset Capitalized Research And Development DeferredTaxAssetCapitalizedResearchAndDevelopment	10931000
CY2023Q1	accd	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	10086000
CY2022Q1	accd	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	10027000
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	94000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175610000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125810000
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7696000
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	23806000
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	7478000
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	8494000
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	19091000
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7478000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	27585000
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	218000
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3779000
CY2023Q1	accd	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	0
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	59213000
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	54101000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125810000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	96516000
CY2023	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Net Operating Losses And Temporary Differences Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToNetOperatingLossesAndTemporaryDifferencesAmount	54937000
CY2022	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Net Operating Losses And Temporary Differences Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToNetOperatingLossesAndTemporaryDifferencesAmount	35287000
CY2023	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Acquisitions Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToAcquisitionsAmount	-5137000
CY2022	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Acquisitions Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToAcquisitionsAmount	-5993000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175610000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125810000
CY2023Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3092000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-50652000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.93
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71279831
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63823270
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29370594
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19140581
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17530371
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8914482
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	3700000
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1218000
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	40323000
CY2023Q1	accd	Purchase Obligation Remaining Future Purchase Commitments PurchaseObligationRemainingFuturePurchaseCommitments	31995000
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	7065000
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	7065000
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	3069000
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	3996000

Files In Submission

Name	View Source	Status
accd-20230228_cal.xml	Edgar Link	unprocessable
accd-20230228_pre.xml	Edgar Link	unprocessable
0001558370-23-007137-index-headers.html	Edgar Link	pending
0001558370-23-007137-index.html	Edgar Link	pending
0001558370-23-007137.txt	Edgar Link	pending
0001558370-23-007137-xbrl.zip	Edgar Link	pending
accd-20230228.xsd	Edgar Link	pending
accd-20230228x10k.htm	Edgar Link	pending
accd-20230228x10k003.jpg	Edgar Link	pending
accd-20230228xex21d1.htm	Edgar Link	pending
accd-20230228xex23d1.htm	Edgar Link	pending
accd-20230228xex31d1.htm	Edgar Link	pending
accd-20230228xex31d2.htm	Edgar Link	pending
accd-20230228xex32d1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
accd-20230228_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
accd-20230228_lab.xml	Edgar Link	unprocessable
accd-20230228x10k_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACCD
Accolade, Inc. Stock $accd

2023 Q2 Form 10-K Financial Statement

#000155837023007137 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACCD Accolade, Inc. Stock $accd

2023 Q2 Form 10-K Financial Statement

#000155837023007137 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACCD
Accolade, Inc. Stock $accd